Subscribe in a reader

Cambridge MedChem Consulting

David Rees BMCS Hall of Fame and Medal 2020

A lot has happened over the last couple of months but I wanted to highlight the latest inductee to the 2020 RSC BMCS Hall of Fame.

The BMCS is delighted to announce that David Rees PhD, FRSC, FMedSci, Chief Scientific Officer at Astex Pharmaceuticals, will be the 2020 inductee to its Hall of Fame, and the recipient of the associated medal. David is recognised internationally for his innovative use of chemistry in drug discovery. His research has forged bridges between academia and industry and he has held prominent positions in learned societies such as the Royal Society of Chemistry. He has led collaborations resulting in the discovery of three launched drugs, the anaesthetic agent Sugammadex which has been used in over 30 million patients in 60 countries, and the anti-cancer agents Ribociclib and Erdafitinib, both predicted to achieve blockbuster status. Much of Astex’s industry-leading productivity has been dependant on David’s chemical expertise. David is well known for his calm authority, scientific rigor and enthusiasm, and has over 140 publications and patents.

The current pandemic means that the formal presentation has been delayed but I'm sure many will want to join me in congratulating David on this well-deserved prestigious award.